Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Japanese polymer microsphere technology development company seeks financing.
| Project region | Japan |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | cancer treatment - exclusive patents applied - cooperation with big Pharma |
|---|---|
| Project description |
The Japanese company is mainly engaged in the development of polymer microsphere technology, which can effectively improve the safety and effectiveness of proteins for cancer treatment. The technologies of protein packaging, protection and release independently developed by the company have applied for exclusive patents. The company has established cooperation with many well-known national and international pharmaceutical enterprises such as Bristol Myers Squibb, Ono Pharmaceutical Co., Merck, Daiichi-Sankyo, GSK and AstraZeneca to jointly promote project research and development ("R&D") and clinical trials. It now seeks financing. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us